OQROGet OQRO Pro
Insider trade

Medtronic (MDT)Officer sold ~$139K

Harry Skip Kiil, Officer at Medtronic, sold ~$139K of Medtronic shares.

~$139K
Approx. value · 1,483 sh @ $93.65
42K
Holds after · shares reported
Traded
Sep 16, 2026
Filed
Sep 18, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 7, 2025CongressDisclosed partial sale of MDT — reported range $1,001 - $15,000
  2. Mar 27, 2026CongressDisclosed purchase of MDT — reported range $1,001 - $15,000
  3. Jul 27, 2026FDAFDA device clearance: Euphora Rapid Exchange (RX) Balloon Dilatation Catheter
  4. Jul 30, 2026CongressDisclosed sale of MDT — reported range $1,001 - $15,000
  5. Jul 31, 2026FDAFDA device clearance: VitalFlow Set with Balance™ Biosurface
  6. Aug 13, 2026FDAFDA device clearance: BIS™ Advance pEEG Module
  7. Aug 14, 2026FDAFDA device clearance: NC Euphora Rapid Exchange Balloon Dilatation Catheter
  8. Aug 21, 2026FDAFDA device clearance: Affera Integrated Mapping System
  9. Aug 24, 2026CongressDisclosed sale of MDT — reported range $15,001 - $50,000
  10. Aug 28, 2026FDAFDA device clearance: LINQ II Insertable Cardiac Monitor (ICM) (LNQ22)
  11. Sep 1, 2026Company filing · Form 8-K · ResultsReported its results
  12. Sep 4, 2026FDAFDA device clearance: ApexCut ™ Blade with Automated EM Tracking (187BL4012EM);ApexCut ™ Blade with Automated EM Tracking (187BL4040EM);ApexCut ™ Blade with Automated EM Tracking (1…
  13. Sep 15, 2026FDAFDA device clearance: LigaSure™ RAS Maryland Jaw Vessel Sealer/Divider, Nano-coated
  14. Sep 16, 2026 · this disclosureInsiderOfficer sold ~$139K of MDT shares in the open market

What came next

  1. Sep 17, 2026FDAFDA device clearance: Protégé™ EverFlex™ Self-expanding Peripheral Stent System
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Medtronic

For Medtronic, OQRO holds 2 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports and 50 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MDT page.

Other recent filings by Harry Skip Kiil, EVP & President Cardiovascular

The full history of Harry Skip Kiil, EVP & President Cardiovascular is on the profile page.

How this filing works

Other disclosures at Medtronic

Everything OQRO holds on this company is on its MDT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data